|
Latest Filings
|
View
|
Form
|
|
Filer
|
Received
|
Period
|
Download / Print
|
Actions
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
10/02/24 |
09/27/24 |
|
|
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
08/27/24 |
08/21/24 |
|
|
|
|
NT 10-Q |
|
EAGLE PHARMACEUTICALS, INC. |
08/09/24 |
06/30/24 |
|
|
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
08/05/24 |
08/01/24 |
|
|
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
07/10/24 |
07/03/24 |
|
|
|
|
SC 13G/A |
|
BLACKROCK FINANCE, INC.
BLACKROCK INC. |
07/08/24 |
|
|
|
|
|
SC 13G |
|
NANTAHALA CAPITAL MANAGEMENT, LLC |
07/03/24 |
|
|
|
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
05/29/24 |
05/28/24 |
|
|
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
05/22/24 |
05/20/24 |
|
|
|
|
8-K |
|
EAGLE PHARMACEUTICALS, INC. |
05/15/24 |
05/14/24 |
|
|
|
|
|
|
Institutional Holders
|
|
Total Number of Holders
|
106
|
% of Shares Outstanding |
91.68%
|
Total Shares Held |
11,906,081
|
Total Value of Holdings |
$10,715,472.90
|
Net Activity |
1,217,421
|
|
|
|
Latest Company News
|
|
Date
|
|
|
|
|
(Quotes provided by Thomson Reuters are delayed by
15
minutes or more.)
|
|